ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial - Buller, Christopher E.; Fu, Yuling; Mahaffey, Kenneth W.; Todaro, Thomas G.; Adams, Peter; Westerhout, Cynthia M.; White, Harvey D.; van 't Hof, Arnoud W.J.; Van de Werf, Frans J.; Wagner, Galen S.; Granger, Christopher B.; Armstrong, Paul W. (Circulation (New York, N.Y.), 2008)
Keywords: Aged; Angioplasty, Balloon, Coronary - mortality; Antibodies, Monoclonal - administration & dosage; Antibodies, Monoclonal, Humanized; Biological and medical sciences; Blood and lymphatic vessels; Cardiology. Vascular system; Cohort Studies; Combined Modality Therapy; Coronary heart disease; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous; Electrocardiography; Female; Heart; Heart Failure - mortality; Humans; Kaplan-Meier Estimate; Male; Medical sciences; Middle Aged; Multivariate Analysis; Myocardial Infarction - diagnosis; Myocardial Infarction - mortality; Myocardial Infarction - therapy; Predictive Value of Tests; Prognosis; Recovery of Function; Shock, Cardiogenic - mortality; Single-Chain Antibodies; Treatment Outcome; Myocardial infarction; Prognosis; ST interval; infarction; Cardiovascular disease; Instrumental dilatation; Pexelizumab; Myocardial disease; Coronary heart disease; Percutaneous route; Immunomodulator; ST elevation; Electrocardiography; Apex; angioplasty